Bioera SpA

Bioera SpA Equity

Delisted

The The Equity of Bioera SpA (BIE.MI) as of Oct 28, 2026 is -15.11 M EUR. In the previous year, The Equity was -5.10 M EUR — a change of 196.14% (lower).

Equity

-15.11 MEUR

YoY

196.14%

Last updated:

In 2023, Bioera SpA's equity was -15.11 M EUR, a 196.14% increase from the -5.10 M EUR equity in the previous year.

The Bioera SpA Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2016
11.82 M EUR
Jan 1, 2017
7.53 M EUR
Jan 1, 2018
5.05 M EUR
Jan 1, 2019
-8.41 M EUR
Jan 1, 2020
-11.58 M EUR
Jan 1, 2021
-1.26 M EUR
Jan 1, 2022
-5.10 M EUR
Jan 1, 2023
-15.11 M EUR
The Bioera SpA Equity history
YEAREquityYoY
-15.11 MEUR+196.14%
-5.10 MEUR+304.20%
-1.26 MEUR-89.10%
-11.58 MEUR+37.78%
-8.41 MEUR-266.48%
5.05 MEUR-32.94%
7.53 MEUR-36.30%
11.82 MEUR-3.91%
12.30 MEUR-22.84%
15.95 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioera SpA Stock analysis

What does Bioera SpA do? Bioera SpA is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Bioera SpA's Equity

Bioera SpA's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bioera SpA's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bioera SpA's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bioera SpA's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bioera SpA’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bioera SpA stock

The Equity of Bioera SpA is -15.11 M EUR in 2023.

The Equity of Bioera SpA changed from -5.10 M EUR to -15.11 M EUR, representing a 196.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Bioera SpA since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Bioera SpA historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bioera SpA

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bioera SpA